110 related articles for article (PubMed ID: 30246955)
1. Prognostic correlation between vitamin D serological levels, Body Mass Index and clinical-pathological features in melanoma patients.
Moliterni E; Paolino G; Veronese N; Bottoni U; Corsetti P; Cardone M; Didona D; Lopez T; Calvieri S
G Ital Dermatol Venereol; 2018 Oct; 153(5):732-733. PubMed ID: 30246955
[No Abstract] [Full Text] [Related]
2. Vitamin D and melanoma: state of the art and possible therapeutic uses.
Paolino G; Moliterni E; Corsetti P; Didona D; Bottoni U; Calvieri S; Mattozzi C
G Ital Dermatol Venereol; 2019 Feb; 154(1):64-71. PubMed ID: 29249122
[TBL] [Abstract][Full Text] [Related]
3. Circulating vitamin D-binding protein and free 25-hydroxyvitamin D concentrations in patients with melanoma: A case-control study.
Navarrete-Dechent C; Del Puerto C; Molgó M; González S; Pérez-Mateluna G; Uribe P; Camargo CA; Borzutzky A
J Am Acad Dermatol; 2017 Sep; 77(3):575-577. PubMed ID: 28807113
[No Abstract] [Full Text] [Related]
4. High serum vitamin D level correlates with better prognostic indicators in primary melanoma: A pilot study.
Lim A; Shayan R; Varigos G
Australas J Dermatol; 2018 Aug; 59(3):182-187. PubMed ID: 28332194
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features, vitamin D serological levels and prognosis in cutaneous melanoma of shield-sites: an update.
Paolino G; Moliterni E; Didona D; Garelli V; Corsetti P; Lopez T; Richetta AG; Cantisani C; Bottoni U; Calvieri S
Med Oncol; 2015 Jan; 32(1):451. PubMed ID: 25516505
[TBL] [Abstract][Full Text] [Related]
6. Sun exposure before and after a diagnosis of cutaneous malignant melanoma: estimated by developments in serum vitamin D, skin pigmentation and interviews.
Idorn LW; Philipsen PA; Wulf HC
Br J Dermatol; 2011 Jul; 165(1):164-70. PubMed ID: 21457211
[TBL] [Abstract][Full Text] [Related]
7. Decreased vitamin D serum levels at melanoma diagnosis are associated with tumor ulceration and high tumor mitotic rate.
Moreno-Arrones OM; Zegeer J; Gerbo M; Manrique-Silva E; Requena C; Traves V; Nagore E
Melanoma Res; 2019 Dec; 29(6):664-667. PubMed ID: 31469708
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D in treated melanoma patients on follow up.
MacKie RM
Br J Dermatol; 2010 Mar; 162(3):697. PubMed ID: 20030636
[No Abstract] [Full Text] [Related]
9. Vitamin D and melanoma and non-melanoma skin cancer risk and prognosis: a comprehensive review and meta-analysis.
Caini S; Boniol M; Tosti G; Magi S; Medri M; Stanganelli I; Palli D; Assedi M; Marmol VD; Gandini S
Eur J Cancer; 2014 Oct; 50(15):2649-58. PubMed ID: 25087185
[TBL] [Abstract][Full Text] [Related]
10. No evidence for reduced 25-hydroxyvitamin D serum level in melanoma patients.
Reichrath J; Querings K
Cancer Causes Control; 2004 Feb; 15(1):97-8. PubMed ID: 15049326
[No Abstract] [Full Text] [Related]
11. Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients.
Nürnberg B; Gräber S; Gärtner B; Geisel J; Pföhler C; Schadendorf D; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3669-74. PubMed ID: 19667163
[TBL] [Abstract][Full Text] [Related]
12. Environmental Exposures Such as Smoking and Low Vitamin D Are Predictive of Poor Outcome in Cutaneous Melanoma rather than Other Deprivation Measures.
Hardie CM; Elliott F; Chan M; Rogers Z; Bishop DT; Newton-Bishop JA
J Invest Dermatol; 2020 Feb; 140(2):327-337.e2. PubMed ID: 31425707
[TBL] [Abstract][Full Text] [Related]
13. Association of 25-hydroxyvitamin D levels and cutaneous melanoma: A nested case-control study of the Women's Health Initiative Observation Study.
Kwon GP; Gamba CS; Stefanick ML; Swetter SM; Li S; Shi RZ; Clarke CA; Feldman D; Millen AE; Messina C; Shikany JM; Manson JE; Chlebowski RT; Tang JY
J Am Acad Dermatol; 2018 Jul; 79(1):145-147. PubMed ID: 29908819
[No Abstract] [Full Text] [Related]
14. Prognostic Value of 25-hydroxyvitamin D3 Levels at Diagnosis and During Follow-up in Melanoma Patients.
Saiag P; Aegerter P; Vitoux D; Lebbé C; Wolkenstein P; Dupin N; Descamps V; Aractingi S; Funck-Brentano E; Autier P; Dragomir M; Boniol M
J Natl Cancer Inst; 2015 Dec; 107(12):djv264. PubMed ID: 26376687
[TBL] [Abstract][Full Text] [Related]
15. The role of serum lactate dehydrogenase level as a prognostic indicator in resected, high risk melanoma.
Kumar AB; Aguilera JV; Velazquez A; Yan Y; Jakub J; Brewer J; Hieken T; Block M; McWilliams R; Otley C; Markovic S; Kottschade L
Dermatol Ther; 2019 Mar; 32(2):e12813. PubMed ID: 30620137
[No Abstract] [Full Text] [Related]
16. RE: Prognostic Value of 25-hydroxyvitamin D3 Levels at Diagnosis and During Follow-up in Melanoma Patients.
Raimondi S; Johansson H; Gandini S
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 27092382
[No Abstract] [Full Text] [Related]
17. Re: Sun exposure and mortality from melanoma.
Kalish RS
J Natl Cancer Inst; 2005 Aug; 97(15):1158; author reply 1159-62. PubMed ID: 16077076
[No Abstract] [Full Text] [Related]
18. [Studies on the prognostic significance of the "stroma reactivity" to malignant melanoma. II. Inflammatory infiltration and prognosis].
Weidner F; Hornstein OP
Virchows Arch A Pathol Pathol Anat; 1973 Mar; 359(1):77-85. PubMed ID: 4633000
[No Abstract] [Full Text] [Related]
19. Monitoring vitamin D in the patient with melanoma: impact of sun avoidance on vitamin D levels of patients with melanoma at a U.K. tertiary-referral melanoma service.
Lo MCI; Maraka J; Garioch J; John WG; Moncrieff M
Br J Dermatol; 2017 Jul; 177(1):282-283. PubMed ID: 27639181
[No Abstract] [Full Text] [Related]
20. Serum 25-hydroxyvitamin D serum levels in a large German cohort of patients with melanoma.
Gambichler T; Bindsteiner M; Höxtermann S; Kreuter A
Br J Dermatol; 2013 Mar; 168(3):625-8. PubMed ID: 22880705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
